by QFR Solutions | Jun 25, 2019 | News
Source: Reuters Drugmaker AbbVie Inc said on Tuesday it would buy Botox-maker Allergan Plc for about $63 billion, grabbing control of the biggest name in medical aesthetics to help reduce its reliance on blockbuster arthritis treatment Humira. AbbVie has been under...
by QFR Solutions | Jun 24, 2019 | News
Source: FiercePharma With the Federal Trade Commission (FTC) sweating the details of Bristol-Myers Squibb and Celgene’s proposed $74 billion merger, all eyes were on the companies’ combined psoriasis portfolio, which regulators feared would corner the market. The feds...
by QFR Solutions | May 28, 2019 | News
Source: PRNewswire DALLAS, May 23, 2019 /PRNewswire/ — Bellus Medical is proud to announce the acquisition of Healeon Medical, Inc.’s HD PRP system for the aesthetic marketplace. This specialized system is designed to meet the demands of busy practices...
by QFR Solutions | Apr 2, 2019 | News
Source: BusinessWire MALVERN, Pa.–(BUSINESS WIRE)–Encore Dermatology Inc. announced today that it has acquired rights for SERNIVO® (betamethasone dipropionate) Spray, 0.05%, as well as rights to market and distribute TRIANEX® 0.05% (Triamcinolone Acetonide...
by QFR Solutions | Mar 26, 2019 | News
Source: PRNewswire DUBLIN, March 26, 2019 /PRNewswire/ — Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced it has completed the acquisition of Envy Medical, Inc., a privately held company with proprietary technology in skin...
